Felix Kesselring is a partner at Bratschi and head of its pharmaceuticals and healthcare industry group. He advises companies in the pharmaceutical, medical devices, life sciences and healthcare sectors and represents his clients before administrative authorities and courts.

Felix Kesselring is a lecturer at the Swiss Federal Institute of Technology (ETH) and a frequent speaker at national and international conferences. He publishes regularly in his fields of expertise.

Felix Kesselring received his law degree from the University of Zurich (lic iur, 2006) and the University of Strasbourg (2004/2005). He holds an LLM in public law from the London School of Economics and Political Science (2012) and received his PhD (Dr iur) from the University of Basel (2017). He has been admitted to the Bar since 2009 and has worked as a seconded legal counsel for a Swiss-based multinational pharmaceutical company. He speaks German, English and French.

Felix Kesselring is a member of the Swiss Association of Jurists (SJV), the Zurich Bar Association (ZAV), the Swiss Bar Association (SAV) and the British-Swiss Chamber of Commerce (BSCC).

Bratschi is one of the largest Swiss law firms with over 100 lawyers and with offices in Zurich, Basel, Berne, Geneva, Lausanne, Zug and St Gallen. It advises its Swiss and international clients in all areas of private and public law.